Search

everythinglearnresearchcommunity

for

Search:↓

Hair color production is closely linked to the active growth phase of hair in mice and may also influence hair growth itself.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

The p75 neurotrophin receptor is important for hair follicle regression by controlling cell death.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Cholesterol sulfate buildup due to a genetic mutation disrupts the skin barrier, leading to the scaling skin seen in X-linked ichthyosis.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Smart biomaterials that guide tissue repair are key for future medical treatments.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Some breast cancer chemotherapy can cause permanent hair loss.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

K16 can partially replace K14 but causes hair loss and skin issues.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

PRP injections may improve skin texture and wrinkles based on patient feedback, despite no significant changes seen by dermatologists.

Improved hair loss treatment using special particles and surfactants.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

ECM molecules are crucial for hair growth and development.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Minoxidil effectively treats female pattern hair loss.

Minoxidil improves blood flow and vessel flexibility, potentially helping with vascular stiffness.